PRIME MEDICINE ANNOUNCES FIRST PATIENT DOSED IN GLOBAL PHASE 1/2 CLINICAL TRIAL OF PM577A FOR H1069Q-MUTATED WILSON DISEASE

Reuters · 3d ago

Please log in to view news